Figure 1.Lipid content in the liver of differently treated mice. (A) Summarized data of the effects of short-term (4 weeks) STZ-, HFD-, LEPR-deficiency (db/db) treatments on circulating glucose and lipid levels. (B) Time course analysis of circulating glucose, TG, TC levels in STZ-treated C57BL/6 mice and control mice (n=3-4, *p<0.05). (C) Time course analysis of circulating glucose, TG, TC levels in HFD-treated C57BL/6 mice and control mice (n=3-4, *p<0.05).
(D) Time course analysis of circulating glucose, TG, TC levels in db/db mice in comparison with wild type mice (n=3-4, *p<0.05). (E–G) Representative image of liver lipid contents detected by oil-red staining in STZ-treated C57BL/6 mice (E), HFD-treated C57BL/6 mice (F) and db/db mice (G).
